Concurrent cisplatin and radiotherapy in advanced head and neck cancer

被引：4
|
作者：
Rehan Asif
Kamlesh Chandra
Vanita Chopra
M. L. B. Bhatt
机构：
[1] Deptt of Otorhmolaryngology,Deptt of Radiotherapy
[2] J N M C Hospital,undefined
[3] A.M U,undefined
来源：
Indian Journal of Otolaryngology and Head and Neck Surgery | 2003年 / 55卷 / 2期
关键词：
Neck Cancer; Bleomycin; Local Tumor Control; Local Tumor Recurrence; Concomitant Chemotherapy;
D O I：
10.1007/BF02974612
中图分类号：
学科分类号：
摘要：
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m2 intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.
引用
收藏
页码：94 / 96
页数：2
相关论文
共 50 条
  • [21] Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer
    Budach, V.
    Becker, E. -T.
    Boehmer, D.
    Badakhshi, H.
    Jahn, U.
    Wernecke, K. -D.
    Stromberger, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) : 250 - 255
  • [22] Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Hamauchi, Satoshi
    Yokota, Tomoya
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Nishimura, Tetsuo
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (12) : 1116 - 1121
  • [23] Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - A review of their cooperation
    Marcu, L
    van Doorn, T
    Olver, I
    ACTA ONCOLOGICA, 2003, 42 (04) : 315 - 325
  • [24] Hyperfractionated radiotherapy with concurrent docetaxel in locally-advanced head and neck cancer
    Karasawa, K.
    Izawa, H.
    Hirowatari, H.
    Ito, K.
    Furuya, T.
    Ozawa, S.
    Matsumoto, F.
    Ito, S.
    Oba, S.
    Ikeda, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [25] Concurrent chemotherapy and radiotherapy for head and neck cancer
    Burri, Ryan J.
    Lee, Nancy Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 293 - 302
  • [26] Docetaxel with concurrent radiotherapy in head and neck cancer
    Nabell, L
    Spencer, S
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 89 - 93
  • [27] Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
    Krishna, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S792 - S793
  • [28] Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC)
    Galper, S. L.
    Deshpande, H.
    Rose, M. G.
    Decker, R. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas
    Levy, Antonin
    Blanchard, Pierre
    Bellefqih, Sara
    Brahimi, Nacera
    Guigay, Joel
    Janot, Francois
    Temam, Stephane
    Bourhis, Jean
    Deutsch, Eric
    Daly-Schveitzer, Nicolas
    Tao, Yungan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (09) : 823 - 831
  • [30] Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial
    Kumar, S
    Pandey, M
    Lal, P
    Rastogi, N
    Das, KJM
    Dimri, K
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) : 186 - 192
12345